 | • レポートコード：QYR9ST03985 • 出版社/出版日：QYResearch / 2019年9月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、93ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療・製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※当調査レポートでは、網膜色素変性症治療＆管理の世界市場について調査・分析し、網膜色素変性症治療＆管理の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（ビタミンA、ドコサヘキサエン酸、カルシウムチャンネルブロッカー、遺伝子治療、網膜眼球補綴）、用途別（病院、外来手術センター、その他）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の網膜色素変性症治療＆管理市場動向 ・主要企業別マーケットシェア ・網膜色素変性症治療＆管理の種類別市場規模2014-2019 （ビタミンA、ドコサヘキサエン酸、カルシウムチャンネルブロッカー、遺伝子治療、網膜眼球補綴） ・網膜色素変性症治療＆管理の用途別市場規模2014-2019 （病院、外来手術センター、その他） ・網膜色素変性症治療＆管理の北米市場：主要企業・種類別/用途別市場規模 ・網膜色素変性症治療＆管理のヨーロッパ市場：主要企業・種類別/用途別市場規模 ・網膜色素変性症治療＆管理の中国市場：主要企業・種類別/用途別市場規模 ・網膜色素変性症治療＆管理の日本国内市場：主要企業・種類別/用途別市場規模 ・網膜色素変性症治療＆管理の東南アジア市場：主要企業・種類別/用途別市場規模 ・網膜色素変性症治療＆管理のインド市場：主要企業・種類別/用途別市場規模 ・網膜色素変性症治療＆管理の中南米市場：主要企業・種類別/用途別市場規模 ・主要企業のプロフィール （ReNeuron、Amarantus BioScience、Ocugen、ReGenX Biosciences、Sucampo Pharmaceuticals、Orphagen Pharmaceuticals、Okuvision、Second Sight Medical） ・網膜色素変性症治療＆管理の市場規模予測2019-2025 （種類別、用途別、地域別市場予測） ・アナリストの観点・結論 ... |
Retinitis pigmentosa (RP) is a genetic disorder of the eyes that causes loss of vision.Retinitis pigmentosa is generally inherited from a person’s parents. Mutations in one of more than 50 genes is involved.
In 2018, the global Retinitis Pigmentosa Treatment & Management market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Retinitis Pigmentosa Treatment & Management status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Retinitis Pigmentosa Treatment & Management development in United States, Europe and China.
The key players covered in this study
ReNeuron
Amarantus BioScience
Ocugen
ReGenX Biosciences
Sucampo Pharmaceuticals
Orphagen Pharmaceuticals
Okuvision
Second Sight Medical
Market segment by Type, the product can be split into
Vitamin A
Docosahexaenoic Acid
Calcium Channel Blockers
Gene Therapy
Retinal Eye Prosthetics
Market segment by Application, split into
Hospitals
Ambulatory Surgical Centers
Others
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Retinitis Pigmentosa Treatment & Management status, future forecast, growth opportunity, key market and key players.
To present the Retinitis Pigmentosa Treatment & Management development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Retinitis Pigmentosa Treatment & Management are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Retinitis Pigmentosa Treatment & Management Market Size Growth Rate by Type (2014-2025)
1.4.2 Vitamin A
1.4.3 Docosahexaenoic Acid
1.4.4 Calcium Channel Blockers
1.4.5 Gene Therapy
1.4.6 Retinal Eye Prosthetics
1.5 Market by Application
1.5.1 Global Retinitis Pigmentosa Treatment & Management Market Share by Application (2014-2025)
1.5.2 Hospitals
1.5.3 Ambulatory Surgical Centers
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Retinitis Pigmentosa Treatment & Management Market Size
2.2 Retinitis Pigmentosa Treatment & Management Growth Trends by Regions
2.2.1 Retinitis Pigmentosa Treatment & Management Market Size by Regions (2014-2025)
2.2.2 Retinitis Pigmentosa Treatment & Management Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Retinitis Pigmentosa Treatment & Management Market Size by Manufacturers
3.1.1 Global Retinitis Pigmentosa Treatment & Management Revenue by Manufacturers (2014-2019)
3.1.2 Global Retinitis Pigmentosa Treatment & Management Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Retinitis Pigmentosa Treatment & Management Market Concentration Ratio (CR5 and HHI)
3.2 Retinitis Pigmentosa Treatment & Management Key Players Head office and Area Served
3.3 Key Players Retinitis Pigmentosa Treatment & Management Product/Solution/Service
3.4 Date of Enter into Retinitis Pigmentosa Treatment & Management Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Retinitis Pigmentosa Treatment & Management Market Size by Type (2014-2019)
4.2 Global Retinitis Pigmentosa Treatment & Management Market Size by Application (2014-2019)
5 United States
5.1 United States Retinitis Pigmentosa Treatment & Management Market Size (2014-2019)
5.2 Retinitis Pigmentosa Treatment & Management Key Players in United States
5.3 United States Retinitis Pigmentosa Treatment & Management Market Size by Type
5.4 United States Retinitis Pigmentosa Treatment & Management Market Size by Application
6 Europe
6.1 Europe Retinitis Pigmentosa Treatment & Management Market Size (2014-2019)
6.2 Retinitis Pigmentosa Treatment & Management Key Players in Europe
6.3 Europe Retinitis Pigmentosa Treatment & Management Market Size by Type
6.4 Europe Retinitis Pigmentosa Treatment & Management Market Size by Application
7 China
7.1 China Retinitis Pigmentosa Treatment & Management Market Size (2014-2019)
7.2 Retinitis Pigmentosa Treatment & Management Key Players in China
7.3 China Retinitis Pigmentosa Treatment & Management Market Size by Type
7.4 China Retinitis Pigmentosa Treatment & Management Market Size by Application
8 Japan
8.1 Japan Retinitis Pigmentosa Treatment & Management Market Size (2014-2019)
8.2 Retinitis Pigmentosa Treatment & Management Key Players in Japan
8.3 Japan Retinitis Pigmentosa Treatment & Management Market Size by Type
8.4 Japan Retinitis Pigmentosa Treatment & Management Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Retinitis Pigmentosa Treatment & Management Market Size (2014-2019)
9.2 Retinitis Pigmentosa Treatment & Management Key Players in Southeast Asia
9.3 Southeast Asia Retinitis Pigmentosa Treatment & Management Market Size by Type
9.4 Southeast Asia Retinitis Pigmentosa Treatment & Management Market Size by Application
10 India
10.1 India Retinitis Pigmentosa Treatment & Management Market Size (2014-2019)
10.2 Retinitis Pigmentosa Treatment & Management Key Players in India
10.3 India Retinitis Pigmentosa Treatment & Management Market Size by Type
10.4 India Retinitis Pigmentosa Treatment & Management Market Size by Application
11 Central & South America
11.1 Central & South America Retinitis Pigmentosa Treatment & Management Market Size (2014-2019)
11.2 Retinitis Pigmentosa Treatment & Management Key Players in Central & South America
11.3 Central & South America Retinitis Pigmentosa Treatment & Management Market Size by Type
11.4 Central & South America Retinitis Pigmentosa Treatment & Management Market Size by Application
12 International Players Profiles
12.1 ReNeuron
12.1.1 ReNeuron Company Details
12.1.2 Company Description and Business Overview
12.1.3 Retinitis Pigmentosa Treatment & Management Introduction
12.1.4 ReNeuron Revenue in Retinitis Pigmentosa Treatment & Management Business (2014-2019)
12.1.5 ReNeuron Recent Development
12.2 Amarantus BioScience
12.2.1 Amarantus BioScience Company Details
12.2.2 Company Description and Business Overview
12.2.3 Retinitis Pigmentosa Treatment & Management Introduction
12.2.4 Amarantus BioScience Revenue in Retinitis Pigmentosa Treatment & Management Business (2014-2019)
12.2.5 Amarantus BioScience Recent Development
12.3 Ocugen
12.3.1 Ocugen Company Details
12.3.2 Company Description and Business Overview
12.3.3 Retinitis Pigmentosa Treatment & Management Introduction
12.3.4 Ocugen Revenue in Retinitis Pigmentosa Treatment & Management Business (2014-2019)
12.3.5 Ocugen Recent Development
12.4 ReGenX Biosciences
12.4.1 ReGenX Biosciences Company Details
12.4.2 Company Description and Business Overview
12.4.3 Retinitis Pigmentosa Treatment & Management Introduction
12.4.4 ReGenX Biosciences Revenue in Retinitis Pigmentosa Treatment & Management Business (2014-2019)
12.4.5 ReGenX Biosciences Recent Development
12.5 Sucampo Pharmaceuticals
12.5.1 Sucampo Pharmaceuticals Company Details
12.5.2 Company Description and Business Overview
12.5.3 Retinitis Pigmentosa Treatment & Management Introduction
12.5.4 Sucampo Pharmaceuticals Revenue in Retinitis Pigmentosa Treatment & Management Business (2014-2019)
12.5.5 Sucampo Pharmaceuticals Recent Development
12.6 Orphagen Pharmaceuticals
12.6.1 Orphagen Pharmaceuticals Company Details
12.6.2 Company Description and Business Overview
12.6.3 Retinitis Pigmentosa Treatment & Management Introduction
12.6.4 Orphagen Pharmaceuticals Revenue in Retinitis Pigmentosa Treatment & Management Business (2014-2019)
12.6.5 Orphagen Pharmaceuticals Recent Development
12.7 Okuvision
12.7.1 Okuvision Company Details
12.7.2 Company Description and Business Overview
12.7.3 Retinitis Pigmentosa Treatment & Management Introduction
12.7.4 Okuvision Revenue in Retinitis Pigmentosa Treatment & Management Business (2014-2019)
12.7.5 Okuvision Recent Development
12.8 Second Sight Medical
12.8.1 Second Sight Medical Company Details
12.8.2 Company Description and Business Overview
12.8.3 Retinitis Pigmentosa Treatment & Management Introduction
12.8.4 Second Sight Medical Revenue in Retinitis Pigmentosa Treatment & Management Business (2014-2019)
12.8.5 Second Sight Medical Recent Development
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
Table Retinitis Pigmentosa Treatment & Management Key Market Segments
Table Key Players Retinitis Pigmentosa Treatment & Management Covered
Table Global Retinitis Pigmentosa Treatment & Management Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Retinitis Pigmentosa Treatment & Management Market Size Market Share by Type 2014-2025
Figure Vitamin A Figures
Table Key Players of Vitamin A
Figure Docosahexaenoic Acid Figures
Table Key Players of Docosahexaenoic Acid
Figure Calcium Channel Blockers Figures
Table Key Players of Calcium Channel Blockers
Figure Gene Therapy Figures
Table Key Players of Gene Therapy
Figure Retinal Eye Prosthetics Figures
Table Key Players of Retinal Eye Prosthetics
Table Global Retinitis Pigmentosa Treatment & Management Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospitals Case Studies
Figure Ambulatory Surgical Centers Case Studies
Figure Others Case Studies
Figure Retinitis Pigmentosa Treatment & Management Report Years Considered
Table Global Retinitis Pigmentosa Treatment & Management Market Size 2014-2025 (Million US$)
Figure Global Retinitis Pigmentosa Treatment & Management Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Retinitis Pigmentosa Treatment & Management Market Size by Regions 2014-2025 (Million US$)
Table Global Retinitis Pigmentosa Treatment & Management Market Size by Regions 2014-2019 (Million US$)
Table Global Retinitis Pigmentosa Treatment & Management Market Share by Regions 2014-2019
Figure Global Retinitis Pigmentosa Treatment & Management Market Share by Regions 2014-2019
Figure Global Retinitis Pigmentosa Treatment & Management Market Share by Regions 2019
Table Market Top Trends
Table Global Retinitis Pigmentosa Treatment & Management Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Retinitis Pigmentosa Treatment & Management Market Share by Manufacturers (2014-2019)
Figure Global Retinitis Pigmentosa Treatment & Management Market Share by Manufacturers in 2018
Table Global Retinitis Pigmentosa Treatment & Management Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Retinitis Pigmentosa Treatment & Management Product/Solution/Service
Table Date of Enter into Retinitis Pigmentosa Treatment & Management Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Retinitis Pigmentosa Treatment & Management Market Size by Type (2014-2019) (Million US$)
Table Global Retinitis Pigmentosa Treatment & Management Market Size Share by Type (2014-2019)
Figure Global Retinitis Pigmentosa Treatment & Management Market Size Market Share by Type (2014-2019)
Table Global Retinitis Pigmentosa Treatment & Management Market Size by Application (2014-2019) (Million US$)
Table Global Retinitis Pigmentosa Treatment & Management Market Size Share by Application (2014-2019)
Figure Global Retinitis Pigmentosa Treatment & Management Market Size Market Share by Application (2014-2019)
Figure Global Retinitis Pigmentosa Treatment & Management Revenue Market Share by Application in 2018
Figure United States Retinitis Pigmentosa Treatment & Management Market Size 2014-2019 (Million US$)
Table United States Key Players Retinitis Pigmentosa Treatment & Management Revenue (2018-2019) (Million US$)
Table United States Key Players Retinitis Pigmentosa Treatment & Management Market Share (2018-2019)
Table United States Retinitis Pigmentosa Treatment & Management Market Size by Type (2014-2019) (Million US$)
Table United States Retinitis Pigmentosa Treatment & Management Market Share by Type (2014-2019)
Table United States Retinitis Pigmentosa Treatment & Management Market Size by Application (2014-2019) (Million US$)
Table United States Retinitis Pigmentosa Treatment & Management Market Share by Application (2014-2019)
Figure Europe Retinitis Pigmentosa Treatment & Management Market Size 2014-2019 (Million US$)
Table Europe Key Players Retinitis Pigmentosa Treatment & Management Revenue (2018-2019) (Million US$)
Table Europe Key Players Retinitis Pigmentosa Treatment & Management Market Share (2018-2019)
Table Europe Retinitis Pigmentosa Treatment & Management Market Size by Type (2014-2019) (Million US$)
Table Europe Retinitis Pigmentosa Treatment & Management Market Share by Type (2014-2019)
Table Europe Retinitis Pigmentosa Treatment & Management Market Size by Application (2014-2019) (Million US$)
Table Europe Retinitis Pigmentosa Treatment & Management Market Share by Application (2014-2019)
Figure China Retinitis Pigmentosa Treatment & Management Market Size 2014-2019 (Million US$)
Table China Key Players Retinitis Pigmentosa Treatment & Management Revenue (2018-2019) (Million US$)
Table China Key Players Retinitis Pigmentosa Treatment & Management Market Share (2018-2019)
Table China Retinitis Pigmentosa Treatment & Management Market Size by Type (2014-20189) (Million US$)
Table China Retinitis Pigmentosa Treatment & Management Market Share by Type (2014-2019)
Table China Retinitis Pigmentosa Treatment & Management Market Size by Application (2014-2019) (Million US$)
Table China Retinitis Pigmentosa Treatment & Management Market Share by Application (2014-2019)
Figure Japan Retinitis Pigmentosa Treatment & Management Market Size 2014-2019 (Million US$)
Table Japan Key Players Retinitis Pigmentosa Treatment & Management Revenue (2018-2019) (Million US$)
Table Japan Key Players Retinitis Pigmentosa Treatment & Management Market Share (2018-2019)
Table Japan Retinitis Pigmentosa Treatment & Management Market Size by Type (2014-2019) (Million US$)
Table Japan Retinitis Pigmentosa Treatment & Management Market Share by Type (2014-2019)
Table Japan Retinitis Pigmentosa Treatment & Management Market Size by Application (2014-2019) (Million US$)
Table Japan Retinitis Pigmentosa Treatment & Management Market Share by Application (2014-2019)
Figure Southeast Asia Retinitis Pigmentosa Treatment & Management Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Retinitis Pigmentosa Treatment & Management Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Retinitis Pigmentosa Treatment & Management Market Share (2018-2019)
Table Southeast Asia Retinitis Pigmentosa Treatment & Management Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Retinitis Pigmentosa Treatment & Management Market Share by Type (2014-2019)
Table Southeast Asia Retinitis Pigmentosa Treatment & Management Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Retinitis Pigmentosa Treatment & Management Market Share by Application (2014-2019)
Figure India Retinitis Pigmentosa Treatment & Management Market Size 2014-2019 (Million US$)
Table India Key Players Retinitis Pigmentosa Treatment & Management Revenue (2018-2019) (Million US$)
Table India Key Players Retinitis Pigmentosa Treatment & Management Market Share (2018-2019)
Table India Retinitis Pigmentosa Treatment & Management Market Size by Type (2014-2019) (Million US$)
Table India Retinitis Pigmentosa Treatment & Management Market Share by Type (2014-2019)
Table India Retinitis Pigmentosa Treatment & Management Market Size by Application (2014-2019) (Million US$)
Table India Retinitis Pigmentosa Treatment & Management Market Share by Application (2014-2019)
Figure Central & South America Retinitis Pigmentosa Treatment & Management Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Retinitis Pigmentosa Treatment & Management Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Retinitis Pigmentosa Treatment & Management Market Share (2018-2019)
Table Central & South America Retinitis Pigmentosa Treatment & Management Market Size by Type (2014-2019) (Million US$)
Table Central & South America Retinitis Pigmentosa Treatment & Management Market Share by Type (2014-2019)
Table Central & South America Retinitis Pigmentosa Treatment & Management Market Size by Application (2014-2019) (Million US$)
Table Central & South America Retinitis Pigmentosa Treatment & Management Market Share by Application (2014-2019)
Table ReNeuron Company Details
Table ReNeuron Revenue in Retinitis Pigmentosa Treatment & Management Business (2014-2019) (Million US$)
Figure ReNeuron Revenue Growth Rate in Retinitis Pigmentosa Treatment & Management Business (2014-2019)
Table ReNeuron Recent Development
Table Amarantus BioScience Company Details
Table Amarantus BioScience Revenue in Retinitis Pigmentosa Treatment & Management Business (2014-2019)(Million US$)
Figure Amarantus BioScience Revenue Growth Rate in Retinitis Pigmentosa Treatment & Management Business (2014-2019)
Table Amarantus BioScience Recent Development
Table Ocugen Company Details
Table Ocugen Revenue in Retinitis Pigmentosa Treatment & Management Business (2014-2019)(Million US$)
Figure Ocugen Revenue Growth Rate in Retinitis Pigmentosa Treatment & Management Business (2014-2019)
Table Ocugen Recent Development
Table ReGenX Biosciences Company Details
Table ReGenX Biosciences Revenue in Retinitis Pigmentosa Treatment & Management Business (2014-2019)(Million US$)
Figure ReGenX Biosciences Revenue Growth Rate in Retinitis Pigmentosa Treatment & Management Business (2014-2019)
Table ReGenX Biosciences Recent Development
Table Sucampo Pharmaceuticals Company Details
Table Sucampo Pharmaceuticals Revenue in Retinitis Pigmentosa Treatment & Management Business (2014-2019)(Million US$)
Figure Sucampo Pharmaceuticals Revenue Growth Rate in Retinitis Pigmentosa Treatment & Management Business (2014-2019)
Table Sucampo Pharmaceuticals Recent Development
Table Orphagen Pharmaceuticals Company Details
Table Orphagen Pharmaceuticals Revenue in Retinitis Pigmentosa Treatment & Management Business (2014-2019)(Million US$)
Figure Orphagen Pharmaceuticals Revenue Growth Rate in Retinitis Pigmentosa Treatment & Management Business (2014-2019)
Table Orphagen Pharmaceuticals Recent Development
Table Okuvision Company Details
Table Okuvision Revenue in Retinitis Pigmentosa Treatment & Management Business (2014-2019)(Million US$)
Figure Okuvision Revenue Growth Rate in Retinitis Pigmentosa Treatment & Management Business (2014-2019)
Table Okuvision Recent Development
Table Second Sight Medical Company Details
Table Second Sight Medical Revenue in Retinitis Pigmentosa Treatment & Management Business (2014-2019)(Million US$)
Figure Second Sight Medical Revenue Growth Rate in Retinitis Pigmentosa Treatment & Management Business (2014-2019)
Table Second Sight Medical Recent Development
Table Global Retinitis Pigmentosa Treatment & Management Market Size by Regions (Million US$) 2019-2025
Figure Global Retinitis Pigmentosa Treatment & Management Market Size Share by Regions (2019-2025)
Figure Global Retinitis Pigmentosa Treatment & Management Market Size Share by Regions in 2025
Figure United States Retinitis Pigmentosa Treatment & Management Market Size Forecast (2019-2025)(Million USD)
Figure Europe Retinitis Pigmentosa Treatment & Management Market Size Forecast (2019-2025)(Million USD)
Figure China Retinitis Pigmentosa Treatment & Management Market Size Forecast (2019-2025)(Million USD)
Figure Japan Retinitis Pigmentosa Treatment & Management Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Retinitis Pigmentosa Treatment & Management Market Size Forecast (2019-2025)(Million USD)
Figure India Retinitis Pigmentosa Treatment & Management Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Retinitis Pigmentosa Treatment & Management Market Size Forecast (2019-2025)(Million USD)
Table Global Retinitis Pigmentosa Treatment & Management Market Size by Product (2019-2025) (Million US$)
Figure Global Retinitis Pigmentosa Treatment & Management Market Size by Product (2019-2025)
Figure Global Retinitis Pigmentosa Treatment & Management Market Size by Product in 2025
Table Global Retinitis Pigmentosa Treatment & Management Market Size by Application (2019-2025) (Million US$)
Figure Global Retinitis Pigmentosa Treatment & Management Market Size by Application (2019-2025)
Figure Global Retinitis Pigmentosa Treatment & Management Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
サイトメガロウイルス網膜炎の治療の世界市場：市場規模・現状・予測 Ophthalmology is the branch of medical science that deals with the management and study of anatomy, physiology, and diseases related to the human eye. Globally, the incidence of eye disorders and vision loss are becoming major public health issues. Some of the major eye diseases include age-related …- 急性腎障害治療及び管理の世界市場：市場規模・現状・予測 KI happens in people who are already sick and in the hospital. People who are in the intensive care unit (ICU) are even more likely than people who are in other units of the hospital to have AKI. This is because people who need to be in the ICU are already very sick.In 2018, the global Acute Kidney …
- 脳脊髄液（CSF）管理の世界市場：市場規模・現状・予測 CSF is a clear, colorless body fluid found in the brain and spinal cord.CSF occupies the subarachnoid space (between the arachnoid mater and the pia mater) and the ventricular system around and inside the brain and spinal cord. In 2018, the global Cerebral Spinal Fluid (CSF) Management market size w…
- 世界の腫瘍治療用遺伝子治療市場：専門的調査 Gene therapy is the therapeutic delivery of nucleic acid into a patient's cells as a drug to treat disease. Research in gene therapy for cancer is currently focused in multiple areas, including genetically engineered viruses that directly kill cancer cells, gene transfer to alter the abnormal functi…
- ムコ多糖症遺伝子治療の世界市場：市場規模・現状・予測 Mucopolysaccharidosis consists of a group of more than 40 genetic disorders that forms a part of lysosomal storage disease. They are caused by an inherited deficiency of an enzyme involved in the degradation of acid glycosaminoglycans (GAGs), which was previously known as mucopolysaccharidosis. All …